Third, the matching methods adopted in this study mimicked a randomized controlled trial, which provides a higher level of evidence
Canakis A, Haroon M, Weber HC
However, Thus, questions remain about what happens when individuals stop taking these medications
How long should a research cycle run
10.3724/abbs.2024150 Summary Keywords atherosclerosis, biomarkers, cardiometabolic disease, endothelial dysfunction, GLP-1RA, macrovascular complications, oxidized LDL (oxLDL), type 2 diabetes Citation Al-Taweel R and Malki A (2026) Role of glucagon-like peptide-1 receptor agonists in type 2 diabetes-associated atherosclerosis: from vascular mechanism to omics-based biomarkers and imaging
What if your semaglutide was delivered warm